Fasudil (a rho-kinase inhibitor) may specifically increase rCBF in spastic area

Acta Neurochirurgica, Supplementum

Volumn , Issue 104, 2008, Pages 275-278

  Shibuya, Masato ^a   Ikeda, A ^a   Ohsuka, K ^b   Yamamoto, Y ^b   Satoh, S ^c  

^a CHUKYO HOSPITAL   (Japan)

^b Kainan Hospital   (Japan)

^c ASAHI KASEI PHARMA CORPORATION   (Japan)

Author keywords

cerebral infarction; Cerebral vasospasm; fasudil; NO; rho kinase; statin; subarachnoid haemorrhage

Indexed keywords

CALCIUM ANTAGONIST; FASUDIL; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN VASOSPASM; CLINICAL ARTICLE; CONFERENCE PAPER; DRUG EFFECT; HUMAN; HYPOTENSION; NEUROLOGIC EXAMINATION; NEUROPROTECTION; SUBARACHNOID HEMORRHAGE;

EID: 77957603785     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-75718-5_56     Document Type: Conference Paper

References (15)

1. Budzyn K, Marley PD, Sobey CG (2006) Targeting Rho and Rhokinase in the treatment of cardiovascular diseases. Trends Pharmacol Sci 27:97-104
2. Dumont AS, Dumont RJ, Chow MM, Lin CL, Calisaneller T, Ley KF, Kassell NF, Lee KS (2003) Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 53:123-135
3. Kimura K, Ito M, Amano M, Chihara K et al. (1996) Regulation of myosin phosphatase by rho and rho-associated kinase (rho-kinase). Science 273:245-248
4. Laufs U, Liao JK (1998) Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 273:24266-24271
5. Matsuda H, Azuma S, Kinuya K, et al (1990) Measurement of cerebral blood flow with 99mTc-HMPAO before and after acetazolamide injection. Nucl Med 27:485-491 (in Japanese)
6. Miyagi Y, Carpenter RC, Meguro T, et al (2000) Upregulation of rho A and rho kinase messenger RNAs in the basilar artery of a rat model of subarachnoid hemorrhage. J Neurosurg 93:471-476
7. Pluta RM (2005) Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol Ther 105:23-56
8. Ono K Shirotani T, Yuba K, Yamana D (2005) Cerebral circulation dynamics following fasudil intravenous infusion: a CT perfusion study. Brain Nerve (Tokyo) 57:779-783 (abstract in English)
9. Sato M, Tani E, Fujikawa H, Kaibuchi K (2000) Involvement of rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circ Res 87:195-200
10. Seto M, Sasaki Y (1999) Diphosphorylation of myosin light chain and spastic contraction of smooth muscle. In: Kohama K, Sasaki Y (eds) Molecular mechanism of smooth muscle contraction. Molecular Biology Intelligence Unit 5. R. G. Landes Co., Austin, Texas pp 97-106
11. Shibuya M, Suzuki Y, Sugita K, et al (1992) Effect of AT877 on cerebral vasospasm after subarachnoid hemorrhage. Results of a prospective placebo-controlled double blind trial. J Neurosurg 76:571-577
12. Shibuya M, Hirai S, Seto M, Satoh S, Ohtomo E (2005) Effects of fasudil in ischemic stroke: results of a prospective placebocontrolled double blind trial. J Neurol Sci 238:31-39
13. Tachibana E, Harada T, Shibuya M, et al (1999) Intraarterial infusion of fasudil hydrochloride for treating vasospasm following subarachnoid hemorrhage. Acta Neurochir (Wien) 141:13-19
14. Tseng MY, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ (2005) Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage. A phase II randomized placebo-controlled trial. Stroke 36:1627-1632
15. Ueda T (2000) Effect on increase of cerebral blood flow with cerebral vasospasm by fasudil-hydrochloride. Med Pharmacy (Tokyo) 42:753-759